Date published: 2026-5-7

1-800-457-3801

SCBT Portrait Logo
Seach Input

AKR1B10 Inhibitors

AKR1B10 inhibitors are a class of chemical compounds that exhibit a unique ability to selectively target and effectively inhibit the enzymatic activity of Aldo-Keto Reductase 1B10 (AKR1B10). This enzyme, categorized within the broader aldo-keto reductase superfamily, finds expression predominantly in distinct human tissues, with notable presence in the liver and lungs. At its core, AKR1B10 catalyzes the reduction of diverse aldehydes and carbonyl compounds, converting them into corresponding alcohols. This biochemical transformation holds significance in several intricate cellular processes, including but not limited to lipid metabolism modulation, detoxification reactions, and participation in specific cellular signaling pathways.

The development of AKR1B10 inhibitors involves a meticulous and targeted approach to designing molecules that can intricately interact with the active site of the enzyme. By doing so, these inhibitors effectively disrupt the enzyme's normal catalytic functioning.

Consequently, these compounds hold the potential to exert a modulating influence on vital biochemical pathways associated with maintaining cellular redox equilibrium and the overall metabolism of both endogenous and exogenous substrates. Integral to the design and subsequent refinement of AKR1B10 inhibitors is an in-depth comprehension of the enzyme's intricate three-dimensional structural arrangement. This knowledge facilitates a detailed understanding of how the inhibitors bind to the enzyme's active site, thereby obstructing its catalytic cycle. Additionally, the interplay between the inhibitors and the various substrates that AKR1B10 interacts with further elucidates the complexity of this class of compounds. The research and development efforts invested in AKR1B10 inhibitors have profound implications spanning a range of scientific domains, encompassing chemical biology, biochemistry, and enzymology. By focusing on the intricacies of AKR1B10 inhibition, researchers gain insight into the complexities of cellular biochemistry and lay the foundation for potential advancements in areas such as enzyme modulation, metabolic regulation, and the elucidation of intricate cellular pathways.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Epalrestat

82159-09-9sc-218319
10 mg
$200.00
2
(1)

An inhibitor of AKR1B10 used for diabetic neuropathy.

Ebselen

60940-34-3sc-200740B
sc-200740
sc-200740A
1 mg
25 mg
100 mg
$33.00
$136.00
$458.00
5
(1)

Multifunctional compound studied for AKR1B10 inhibition and other effects.